Price T Rowe Associates Inc Emergent Bio Solutions Inc. Transaction History

Price T Rowe Associates Inc

$867 Billion
Q4 2024

A detailed history of Price T Rowe Associates Inc transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 11,800 shares of EBS stock, worth $114,696. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,800

Previous 11,800 -0.0%

Holding current value

$114,696

Previous $99,000 14.14%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$5.72 - $14.77 $67,496 - $174,286	11,800 New	11,800 $99,000
Q1 2024 May 15, 2024	BUY	$1.5 - $3.41 $6,613 - $15,034	4,409 Added 22.57%	23,943 $61,000
Q4 2023 Feb 14, 2024	BUY	$1.82 - $3.16 $2,436 - $4,231	1,339 Added 7.36%	19,534 $47,000
Q3 2023 Nov 14, 2023	SELL	$3.17 - $7.91 $30,099 - $75,105	-9,495 Reduced 34.29%	18,195 $62,000
Q2 2023 Aug 14, 2023	BUY	$7.35 - $13.21 $29,833 - $53,619	4,059 Added 17.18%	27,690 $204,000
Q1 2023 May 15, 2023	BUY	$7.79 - $16.29 $7,120 - $14,889	914 Added 4.02%	23,631 $245,000
Q4 2022 Feb 14, 2023	SELL	$11.0 - $21.45 $59,642 - $116,301	-5,422 Reduced 19.27%	22,717 $268,000
Q3 2022 Nov 14, 2022	SELL	$20.09 - $35.8 $2.11 Million - $3.75 Million	-104,788 Reduced 78.83%	28,139 $592,000
Q2 2022 Aug 15, 2022	SELL	$27.42 - $43.63 $3.26 Million - $5.18 Million	-118,762 Reduced 47.19%	132,927 $4.13 Million
Q1 2022 May 16, 2022	SELL	$36.48 - $52.22 $743,608 - $1.06 Million	-20,384 Reduced 7.49%	251,689 $10.3 Million
Q4 2021 Feb 14, 2022	SELL	$33.11 - $55.01 $8.89 Million - $14.8 Million	-268,476 Reduced 49.67%	272,073 $11.8 Million
Q3 2021 Nov 15, 2021	SELL	$50.07 - $66.05 $675,294 - $890,816	-13,487 Reduced 2.43%	540,549 $27.1 Million
Q2 2021 Aug 16, 2021	SELL	$56.61 - $80.46 $12.5 Million - $17.8 Million	-221,018 Reduced 28.52%	554,036 $34.9 Million
Q1 2021 May 17, 2021	SELL	$86.23 - $125.19 $8.39 Million - $12.2 Million	-97,313 Reduced 11.16%	775,054 $72 Million
Q4 2020 Feb 16, 2021	BUY	$79.17 - $111.47 $69.1 Million - $97.2 Million	872,367 New	872,367 $78.2 Million

Others Institutions Holding EBS

# of Institutions

172

Shares Held

36.8M

Call Options Held

336K

Put Options Held

203K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $485M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Emergent Bio Solutions Inc. Transaction History